03/10/2022

Neoadjuvant immunotherapy as a promising approach in melanoma and colon cancer

26/09/2022

Benefits of pralsetinib in patients with RET fusions

19/09/2022

Outcomes of neoadjuvant durvalumab in triple-negative breast cancer – Experts’ comment

14/09/2022

Dosing of first three patients in the first-in-human study with selective N-glycosylation inhibitors

05/09/2022

Positive results with pembrolizumab in advanced triple-negative breast cancer

29/08/2022

Cancer vaccines, present and future

22/08/2022

Amcenestrant in post-menopausal women with ER-positive/HER2-negative advanced breast cancer

01/08/2022

More than 100.000 cases in the AACR Project GENIE

25/07/2022

Durable clinical benefits in lung cancer with a KRASG12C inhibitor